Stem Cell Collection

PROCEDURE5 trials

Sponsors

M.D. Anderson Cancer Center, Columbia University, Dana-Farber Cancer Institute, Boston Medical Center, Washington University School of Medicine

Conditions

AL AmyloidosisAstrocytomaBrainstem GliomaEpendymomaLymphomaMixed GliomaMultiple MyelomaOligodendroglioma

Early Phase 1

Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade Gliomas

WithdrawnNCT02976441

Washington University School of MedicineAstrocytoma, Brainstem Glioma, Ependymoma +3

Start: 2017-01-31End: 2018-02-28Updated: 2017-02-20

Phase 2

Chemotherapy Plus Ofatumumab Followed by G-CSF for Mobilization of Peripheral Blood Stem Cells in Patients With Non-Hodgkin's Lymphomas

CompletedNCT01329900

M.D. Anderson Cancer CenterLymphoma

Start: 2011-08-22End: 2019-07-21Updated: 2020-07-08

CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma

TerminatedNCT01746173

Dana-Farber Cancer InstituteT-cell Non-Hodgkin Lymphoma

Start: 2013-07-31End: 2014-10-31Updated: 2023-01-30

Phase 3

Trial of High Dose Melphalan/Stem Cell Transplant With or Without Bortezomib

TerminatedNCT02489500

Boston Medical CenterAL Amyloidosis

Start: 2015-06-30End: 2017-04-28Updated: 2018-09-10

Phase 4

Lenalidomide and Dexamethasone With/Without Stem Cell Transplant in Patients With Multiple Myeloma

CompletedNCT01731886

Columbia UniversityMultiple Myeloma

Start: 2012-09-30End: 2017-04-11Updated: 2020-02-05

Related Papers

Continuous Treatment with Lenalidomide Plus Low-Dose Dexamethasone (Ld) Versus Ld Induction Followed By Autologous Stem Cell Transplant (ASCT) in Patients with Newly Diagnosed Multiple Myeloma (NDMM): A Pooled Analysis of Two Randomized Clinical Trials

Blood2015-12-03

Lenalidomide and low-dose dexamethasone (Ld) is equivalent to Ld plus autologous stem cell transplant (ASCT) in newly diagnosed multiple myeloma (NDMM): Results of a randomized, phase III trial.

Journal of Clinical Oncology2015-05-20